Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
AHCO 
Adapthealth Corp (AHCO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/08/2025: AHCO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $13.25
1 Year Target Price $13.25
| 5 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -76.2% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/08/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.27B USD | Price to earnings Ratio 17.07 | 1Y Target Price 13.25 |
Price to earnings Ratio 17.07 | 1Y Target Price 13.25 | ||
Volume (30-day avg) 8 | Beta 1.77 | 52 Weeks Range 7.11 - 11.63 | Updated Date 12/9/2025 |
52 Weeks Range 7.11 - 11.63 | Updated Date 12/9/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.55 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.53% | Operating Margin (TTM) 8.18% |
Management Effectiveness
Return on Assets (TTM) 3.64% | Return on Equity (TTM) 5.52% |
Valuation
Trailing PE 17.07 | Forward PE 8.21 | Enterprise Value 3099280226 | Price to Sales(TTM) 0.39 |
Enterprise Value 3099280226 | Price to Sales(TTM) 0.39 | ||
Enterprise Value to Revenue 0.95 | Enterprise Value to EBITDA 4.85 | Shares Outstanding 135424334 | Shares Floating 88019266 |
Shares Outstanding 135424334 | Shares Floating 88019266 | ||
Percent Insiders 8.13 | Percent Institutions 104.06 |
Upturn AI SWOT
Adapthealth Corp
Company Overview
History and Background
AdaptHealth Corp. was founded in 2013 and has since grown into a significant player in the healthcare technology and services sector. The company has achieved substantial growth through a combination of organic expansion and strategic acquisitions, focusing on providing home healthcare solutions and medical equipment. Key milestones include its IPO and subsequent acquisitions that have broadened its service offerings and geographic reach.
Core Business Areas
- Home Healthcare Services and Equipment: Provision of durable medical equipment (DME), home respiratory therapy, sleep apnea treatment, and other chronic condition management solutions directly to patients in their homes.
- HME and Respiratory Products: Distribution of a wide range of home medical equipment, including oxygen concentrators, CPAP machines, mobility devices, and wound care supplies.
- Reimbursement and Billing Services: Offering specialized services to healthcare providers for managing insurance claims, billing, and revenue cycle management related to medical equipment and services.
Leadership and Structure
AdaptHealth Corp. is led by a management team with extensive experience in the healthcare industry. The organizational structure is designed to support its diverse service lines and geographic operations, with a focus on integrating acquired entities and streamlining operations for efficiency and patient care.
Top Products and Market Share
Key Offerings
- Respiratory Therapy Solutions: Includes CPAP/BiPAP machines and supplies for sleep apnea, as well as oxygen concentrators and portable oxygen solutions for respiratory conditions. Competitors include Lincare (a division of Linde), Apria Healthcare, and various smaller regional DME providers. Specific market share data for individual product lines is not publicly disclosed but is a significant portion of AdaptHealth's revenue.
- Durable Medical Equipment (DME): Encompasses a broad range of equipment such as wheelchairs, walkers, hospital beds, and other assistive devices for mobility and daily living. Market share is fragmented across many national and local providers. Key competitors include established DME suppliers and general medical equipment distributors.
- Diabetes Care Products: Offers continuous glucose monitoring (CGM) systems, insulin pumps, and related supplies. Competitors include major diabetes technology companies like Dexcom, Abbott, and Medtronic.
Market Dynamics
Industry Overview
The home healthcare and durable medical equipment industry is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards home-based care. Reimbursement policies from Medicare, Medicaid, and private insurers significantly influence market dynamics. Technological advancements in remote patient monitoring and telehealth are also shaping the industry.
Positioning
AdaptHealth is positioned as a leading provider of home healthcare solutions, leveraging its scale, integrated service model, and strategic acquisitions to capture market share. Its focus on patient-centric care and a broad range of product and service offerings provides a competitive advantage.
Total Addressable Market (TAM)
The TAM for home healthcare and DME in the US is estimated to be in the tens of billions of dollars, driven by an increasing number of elderly individuals and those with chronic conditions requiring ongoing care. AdaptHealth holds a significant, though not dominant, share of this market, with substantial room for further penetration and expansion.
Upturn SWOT Analysis
Strengths
- Extensive product and service portfolio
- Strong track record of successful acquisitions and integration
- Broad geographic reach across the United States
- Established relationships with payors and healthcare providers
- Focus on chronic disease management
Weaknesses
- Reliance on reimbursement policies
- Integration challenges post-acquisition
- Competition from larger integrated healthcare systems
- Potential for regulatory changes impacting profitability
Opportunities
- Growing demand for home-based care
- Expansion into new therapeutic areas
- Leveraging technology for remote patient monitoring and telehealth
- Further consolidation within the fragmented HME industry
- Partnerships with health systems and payers
Threats
- Changes in Medicare and Medicaid reimbursement rates
- Increased competition and pricing pressure
- Cybersecurity risks and data breaches
- Economic downturns impacting healthcare spending
- Supply chain disruptions for medical equipment
Competitors and Market Share
Key Competitors
- Lincare Holdings Inc. (US Stock Symbol: LIN - though now part of Linde PLC)
- Apria Healthcare (Private, formerly APR)
- Philips Respironics (Part of Koninklijke Philips NV, NYSE: PHG)
- ResMed Inc. (US Stock Symbol: RMD)
- DexCom, Inc. (US Stock Symbol: DXCM)
- Abbott Laboratories (US Stock Symbol: ABT)
- Medtronic plc (US Stock Symbol: MDT)
Competitive Landscape
AdaptHealth competes in a dynamic and fragmented market. Its advantages lie in its scale, comprehensive service offering, and acquisition expertise. Challenges include navigating complex reimbursement environments and fending off competition from both large, established players and agile, specialized providers.
Major Acquisitions
Unknown
- Year: 2023
- Acquisition Price (USD millions):
- Strategic Rationale: To be updated as specific acquisitions are announced. AdaptHealth has a history of acquiring companies to expand its service lines, geographic reach, or technological capabilities.
Growth Trajectory and Initiatives
Historical Growth: AdaptHealth has experienced significant historical growth, largely fueled by its aggressive acquisition strategy. This has led to an expanded footprint and a broader range of services. Organic growth has also contributed, driven by an increasing demand for its core offerings.
Future Projections: Future growth is projected to continue through a combination of strategic acquisitions, market penetration in existing segments, and potential expansion into new service areas. Analyst estimates for future revenue and earnings growth should be reviewed for forward-looking insights.
Recent Initiatives: Recent initiatives have likely focused on integrating recently acquired businesses, optimizing operational efficiencies, expanding digital capabilities for patient engagement and remote monitoring, and strengthening relationships with healthcare providers and payers.
Summary
AdaptHealth Corp. is a prominent player in the home healthcare sector, demonstrating strong growth through strategic acquisitions and a comprehensive service offering. Its focus on chronic disease management and durable medical equipment positions it well within an expanding market. However, the company faces challenges related to reimbursement dependence, integration complexities, and intense competition, necessitating careful navigation of regulatory landscapes and operational efficiencies to sustain its growth trajectory.
Similar Stocks
Sources and Disclaimers
Data Sources:
- AdaptHealth Corp. Investor Relations
- SEC Filings (10-K, 10-Q)
- Industry Reports and Market Research
- Financial News Outlets
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. Market share data and acquisition details may be estimates or based on publicly available information that may not be exhaustive or up-to-date. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Adapthealth Corp
Exchange NASDAQ | Headquaters Plymouth Meeting, PA, United States | ||
IPO Launch date 2018-05-24 | CEO & Director Ms. Suzanne M. Foster M.P.H. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10500 | Website https://adapthealth.com |
Full time employees 10500 | Website https://adapthealth.com | ||
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.